AI brief of an SEC Form 8-K · BrightSpring Health Services (BTSG)

BrightSpring raises 2025 guidance; Q4 revenue up 28.6% to $3,053 million

Positive Impact 4 of 5 guidance Written later

BrightSpring reported fourth-quarter and full-year 2024 results and raised its 2025 revenue and Adjusted EBITDA guidance, excluding the Community Living business it agreed on January 20, 2025 to sell to Sevita for $835 million. Full-year net loss narrowed to $20.5 million from $156.8 million in 2023, while revenue and Adjusted EBITDA both grew.

Key points

  • Q4 2024 net revenue of $3,053 million, up 28.6%; Q4 net income of $15.4 million versus a net loss of $7.2 million in Q4 2023
  • Full-year 2024 net revenue of $11,266 million, up 27.6%; Adjusted EBITDA of $588 million, up 9.3%
  • 2025 guidance raised: revenue of $11,600 million to $12,100 million and Adjusted EBITDA of $545 million to $560 million, excluding Community Living
  • Community Living divestiture to Sevita for $835 million, subject to customary closing adjustments

The filing

CompanyBrightSpring Health Services (BTSG)
Form8-K, current report
Filed with the SECMar 6, 2025, 6:05 AM ET
Accession number0000950170-25-034152

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 06, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.